BRAF and melanoma: We first performed functional assays to analyze the proliferative (Supplementary Fig. 1Ai) and/or migratory potential (Supplementary Fig. 1Aii) of four melanoma cell lines exhibiting different tumor stages, BRAF mutation statuses, and PTEN deletions.